Knowledge Center
Patent / Jan 01, 1999
Process for the preparation of crystalline and solvent-free iohexol
Source:
AU 696647
An industrial-scale process for the purifn. and removal of residual solvents from the X-ray contrast agent iohexol is presented which is based on the suspension of cryst. iohexol, eventually contg. residual solvents above 100 ppm, in a fluid where it has a low soly. (e.g., EtOH), followed by heating, filtration, and drying. The process allows the formation of cryst. iohexol with a residual org. solvent content of .ltoreq.100 ppm and with an increased purity level.
Also in the Knowledge Center
/ Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Read more
Scientific Article
/ Nov 12, 2024
Webinar - Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology
Read more
Scientific Article
/ Oct 29, 2024
Comparison of Traditional and Mechanochemical Production Processes for Nine Active Pharmaceutical Ingredients (APIs)
Read more
Scientific Article